Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

12/08/2022 07:40

Aug 12 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Jun 30, 2022        Jun 30, 2021      Sep 30, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            112 mln             117 mln           357 mln    
                 (-4.9 pct)          (+91.4 pct)       (+23.4 pct)  
  Operating     loss 383 mln        loss 304 mln      loss 497 mln  
  Recurring     loss 305 mln        loss 245 mln      loss 419 mln  
  Net           loss 306 mln        loss 246 mln      loss 421 mln  
  EPS          loss 65.02 yen      loss 60.13 yen    loss 89.24 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                                            
  -Q4 div                                NIL               NIL      
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T